Bionano Genomics, Inc.
Ticker: 1411690
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.69-9.2% | 7.37+9.5% | 6.73+4.2% | 6.46+6.4% | 6.07-21.9% | 7.77-11.4% | 8.77-5.9% | 9.32 |
| Total Income | 6.69-9.2% | 7.37+9.5% | 6.73+4.2% | 6.46+6.4% | 6.07-21.9% | 7.77-11.4% | 8.77-5.9% | 9.32 |
| EXPENSES | ||||||||
| Expenditure | 11.15-6.4% | 11.91+5.6% | 11.28-1.1% | 11.40-67.9% | 35.46+80.9% | 19.60-42.3% | 33.95-70.7% | 115.96 |
| Tax | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01-50.0% | 0.02-33.3% | 0.03+250.0% | -0.02-150.0% | 0.04 |
| PROFIT | ||||||||
| PBT | -8.29+2.4% | -8.49-23.9% | -6.85-121.0% | -3.10+93.0% | -44.22-173.0% | -16.20+48.5% | -31.44+72.1% | -112.53 |
| Net Profit | -8.30+2.4% | -8.50-23.9% | -6.86-121.3% | -3.10+93.0% | -44.25-172.8% | -16.22+48.4% | -31.42+72.1% | -112.57 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-51.96pp | -48.04%+51.96pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.76+52.2% | -1.59+20.1% | -1.99-73.0% | -1.15-121.2% | -0.52-116.7% | -0.24+60.0% | -0.60+81.4% | -3.22 |
Corporate Events
Board MeetingBNGO
202620Jul
Board Meeting
Appointment of Alex Hastie, Ph.D. as Chief Scientific Office…
SEC Filing ↗ Board MeetingBNGO
202620Jul
Board Meeting
Appointment of Alex Hastie, Ph.D., as Chief Scientific Offic…
SEC Filing ↗ Board MeetingBNGO
20262Jun
Board Meeting
Chief Medical Officer Transition — Alka Chaubey, Ph.D. resig…
SEC Filing ↗ Board MeetingBNGO
202614May
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, appr…
SEC Filing ↗ Board MeetingBNGO
20265May
Board Meeting
Leadership Transition: R. Erik Holmlin terminated as Preside…
SEC Filing ↗